Back

Is atrial fibrillation associated with increased risk of stroke after transient ischaemic attack?

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Stroke risk management in atrial fibrillation registries: key take-home messages for clinicians Stroke in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Katia Al-Chaer

Herlev and Gentofte Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
How much does elective cardioversion increase the risk of ischaemic stroke compared to the baseline risk in atrial fibrillation? A nationwide study.
Mrs S. Itainen-Stromberg (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Stratification of residual thromboembolic risk among anticoagulated atrial fibrillation patients: a hierarchical cluster analysis from a global, real-world population
Doctor H. Ishiguchi (Ube, JP)
Abstract Slides Video
Presentation thumbnail
Cluster-specific risk factors for suboptimal thromboprophylaxis in contemporary European cohort of patients with atrial fibrillation: the EHRA-PATHS Project
Doctor M. Mihajlovic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Temporal trends in initiation of oral anticoagulants and stroke-free survival among elderly and very elderly patients with new onset atrial fibrillation - a 20-year perspective.
Doctor M. Elmegaard (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Stroke risk management in atrial fibrillation registries: key take-home messages for clinicians
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
We really need long-term cardiac rhythm monitoring after embolic stroke of unknown source - discussion
thumbnail
Congress Presentation
State-of-the-art lecture on stroke prevention in atrial fibrillation
thumbnail
Congress Presentation
Atrial fibrillation patients at intermediate risk of stroke rapidly progress to high stroke risk: A nationwide registry study (AFNOR).

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources